126 related articles for article (PubMed ID: 38384049)
1. Evaluation of EGFR in prognostic characterization in histopathological variants of oral squamous cell carcinoma.
Tyagi D; Singhal M; Gulati N; Jain A; Shetty DC
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S743-S746. PubMed ID: 38384049
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
[TBL] [Abstract][Full Text] [Related]
3. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma.
Mehta A; Chowdhary M; Sinha R
J Oral Pathol Med; 2015 Nov; 44(10):818-22. PubMed ID: 25581523
[TBL] [Abstract][Full Text] [Related]
4. The stromal immunoexpression of CLIC4 may be related to the difference in the biological behavior between oral squamous cell carcinoma and oral verrucous carcinoma.
Xerez MC; Barros CC; Queiroz SI; Silveira ÉJ; Costa AD
Med Oral Patol Oral Cir Bucal; 2023 Sep; 28(5):e418-e424. PubMed ID: 37026609
[TBL] [Abstract][Full Text] [Related]
5. Study of the association of the known prognostic variables with EGFR expression in head and neck squamous cell carcinomas.
Jadhav T; Malik A; Kashif AW; Shelly D; Mishra PS; Baranwal AK; Sahu R
Indian J Pathol Microbiol; 2024; 67(1):36-45. PubMed ID: 38358186
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and Clinicopathological Significance of Epidermal Growth Factor Receptor (EGFR) Expression in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.
Cívico-Ortega JL; González-Ruiz I; Ramos-García P; Cruz-Granados D; Samayoa-Descamps V; González-Moles MÁ
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569265
[TBL] [Abstract][Full Text] [Related]
7. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
[TBL] [Abstract][Full Text] [Related]
8. Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling.
Huang Z; Rui X; Yi C; Chen Y; Chen R; Liang Y; Wang Y; Yao W; Xu X; Huang Z
J Exp Clin Cancer Res; 2023 Mar; 42(1):60. PubMed ID: 36899380
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of RAB27A in Oral Squamous Cell Carcinoma Promotes Tumor Migration and Invasion via Modulation of EGFR Membrane Stability.
Huang J; Yang JG; Ren JG; Xia HF; Chen GH; Fu QY; Zhang LZ; Liu HM; Wang KM; Xie QH; Chen G
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685910
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
Sasabe E; Tomomura A; Liu H; Sento S; Kitamura N; Yamamoto T
Cancer Sci; 2022 Feb; 113(2):609-621. PubMed ID: 34874595
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis.
Sarkis SA; Abdullah BH; Abdul Majeed BA; Talabani NG
Head Neck Oncol; 2010 Jun; 2():13. PubMed ID: 20579333
[TBL] [Abstract][Full Text] [Related]
12. Activation of EGFR-Aurora A induces loss of primary cilia in oral squamous cell carcinoma.
Yin F; Chen Q; Shi Y; Xu H; Huang J; Qing M; Zhong L; Li J; Xie L; Zeng X
Oral Dis; 2022 Apr; 28(3):621-630. PubMed ID: 33529425
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of EGFR and MET has a synergistic effect on the prognosis of patients with oral squamous cell carcinoma.
Yokokawa M; Morita KI; Oikawa Y; Kayamori K; Sakamoto K; Ikeda T; Harada H
J Oral Pathol Med; 2020 Mar; 49(3):235-242. PubMed ID: 31762177
[TBL] [Abstract][Full Text] [Related]
14. Association of Stathmin (Op18) with TNM Staging and Grading of Oral Squamous Cell Carcinoma and Its Role in Tumor Progression.
Vadla P; Deepthi G; Julakanti V; Jahagirdar D; Meruva S; Tantravahi S
J Contemp Dent Pract; 2022 May; 23(5):497-502. PubMed ID: 35986456
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
[TBL] [Abstract][Full Text] [Related]
16. Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma.
Tseng YK; Chen CF; Shu CW; Lee CH; Chou YT; Li YJ; Liou HH; Cheng JT; Chen CL; Ger LP; Liu PF
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830108
[TBL] [Abstract][Full Text] [Related]
17. The immunoexpression of epidermal growth factor receptor in cutaneous squamous cell carcinoma.
Nichita MM; Giurcăneanu C; Mihai MM; Ghigulescu M; Beiu C; Negoiţă SI; Popa LG
Rom J Morphol Embryol; 2021; 62(1):201-208. PubMed ID: 34609422
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
19. [Effect of up-regulation of Decorin on expression of EGFR, C-Myc and p21 in nude mice with oral squamous cell carcinoma].
Guo MY; Li KY; Nie MH; Liu XQ
Shanghai Kou Qiang Yi Xue; 2023 Feb; 32(1):40-46. PubMed ID: 36973842
[TBL] [Abstract][Full Text] [Related]
20. The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study.
Solomon MC; Vidyasagar MS; Fernandes D; Guddattu V; Mathew M; Shergill AK; Carnelio S; Chandrashekar C
Med Oncol; 2016 Dec; 33(12):138. PubMed ID: 27817107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
